Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.70 is 33% below its 5-year average of -1.28, near the low end of its 5-year range (-2.01–-0.91).
64.25% below its 12-month average of -1.03.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.79.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.70
EARNINGS PER SHARE (EPS) AVG TTM
-1.03
EARNINGS PER SHARE (EPS) AVG 3Y
-1.29
EARNINGS PER SHARE (EPS) AVG 5Y
-1.28
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-64.25%
CURRENT VS 3Y AVG
-31.78%
CURRENT VS 5Y AVG
-33.16%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Nano-X Imaging Ltd.
Market Cap
$43.66M
Earnings Per Share (EPS)
-1.70
TTM Avg
-1.03
3Y Avg
-1.29
5Y Avg
-1.28
Market Cap
$43.31M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.78
3Y Avg
0.08
5Y Avg
-0.02
Market Cap
$44.40M
Earnings Per Share (EPS)
-1.11
TTM Avg
-1.06
3Y Avg
-1.20
5Y Avg
-1.30
Market Cap
$44.27M
Earnings Per Share (EPS)
-1.98
TTM Avg
-2.34
3Y Avg
-2.17
5Y Avg
-1.92
Market Cap
$44.24M
Earnings Per Share (EPS)
0.69
TTM Avg
-0.78
3Y Avg
-1.53
5Y Avg
-2.71
Market Cap
$44.54M
Earnings Per Share (EPS)
0.90
TTM Avg
-2.83
3Y Avg
-6.22
5Y Avg
-12.54
Market Cap
$44.98M
Earnings Per Share (EPS)
-0.73
TTM Avg
-1.48
3Y Avg
-1.47
5Y Avg
-1.37
Market Cap
$41.76M
Earnings Per Share (EPS)
-0.65
TTM Avg
-1.58
3Y Avg
-4.60
5Y Avg
-6.89
Market Cap
$41.33M
Earnings Per Share (EPS)
-0.60
TTM Avg
-2.17
3Y Avg
-6.45
5Y Avg
-4.61
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | $43.66M | -1.70 | -1.03 | -1.29 | -1.28 |
| BioStem Technologies, Inc. (BSEM)vs › | $43.31M | -1.68 | 0.78 | 0.08 | -0.02 |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.40M | -1.11 | -1.06 | -1.20 | -1.30 |
| CVRx, Inc. (CVRX)vs › | $44.27M | -1.98 | -2.34 | -2.17 | -1.92 |
| DarioHealth Corp. (DRIO)vs › | $44.24M | 0.69 | -0.78 | -1.53 | -2.71 |
| SANUWAVE Health Inc. (SNWV)vs › | $44.54M | 0.90 | -2.83 | -6.22 | -12.54 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.98M | -0.73 | -1.48 | -1.47 | -1.37 |
| Precipio, Inc. (PRPO)vs › | $41.76M | -0.65 | -1.58 | -4.60 | -6.89 |
| Veru Inc. (VERU)vs › | $41.33M | -0.60 | -2.17 | -6.45 | -4.61 |
| Instil Bio, Inc. (TIL)vs › | $46.76M | -4.47 | -11.04 | -20.14 | -19.34 |
Trailing EPS (TTM)
$-1.70
Forward EPS (Est.)
$-1.26
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.16 |
| 2024-12-31 | -0.91 |
| 2023-12-31 | -1.08 |
| 2022-12-31 | -2.01 |
| 2021-12-31 | -1.28 |
| 2020-12-31 | -1.22 |
| 2019-12-31 | -0.49 |
| 2018-12-31 | -0.06 |
